Piper Jaffray Downgrades Regeneron (REGN) to Neutral
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $833.64 +2.89%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Piper Jaffray downgraded Regeneron Pharma (NASDAQ: REGN) from Overweight to Neutral, price target maintained at $81.
For an analyst ratings summary and ratings history on Repligen click here. For more ratings news on Repligen click here.
For an analyst ratings summary and ratings history on Repligen click here. For more ratings news on Repligen click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- JPMorgan Downgrades Cogent Communications (CCOI) to Underweight
- UBS Downgrades Cellnex Telecom (CLNX:SM) (CLNXF) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
